Pugsley Michael K, Authier Simon, Brabham Tiffini, Soloviev Maxim, Markgraf Carrie G, Correll Krystle, Traebert Martin, Greiter-Wilke Andrea, Valentin Jean-Pierre, Vargas Hugo, Botchway Alfred, Leishman Derek J, Curtis Michael J
Purdue Pharma L.P., Cranbury, NJ, USA.
CiToxLAB North America, Laval, QC, Canada.
J Pharmacol Toxicol Methods. 2017 Nov;88(Pt 1):85-91. doi: 10.1016/j.vascn.2017.08.002. Epub 2017 Aug 7.
Safety pharmacology is a growing discipline with scientists broadly distributed across international geographical regions. This electronic salary survey is the first to be distributed amongst the entire Safety Pharmacology Society (SPS) membership. An electronic survey was sent to all members of the Society. Categorical survey questions assessed membership employment types, annual incomes, and professional certifications, along with other associated career attributes.
This survey was distributed to the SPS membership that is comprised of safety pharmacologists, toxicologists and pharmacologists working globally in the pharmaceutical industry, at contract research organizations (CRO), regulatory agencies, and academia or within the technology provider industry. The survey was open for responses from December 2015 to March 2016.
The survey response rate was 28% (129/453). North America (68%) was the region with the largest number of respondents followed by Europe (28%). A preponderance of respondents (77%) had 12years of industry experience or more. 52% of responders earned annually between $40,000 and $120,000. As expected, salary was generally positively correlated with the number of years of experience in the industry or the educational background but there was no correlation between salary and the number of employee's directly supervised. The median salary was higher for male vs female respondents, but so was median age, indicative of no gender 'salary gap'.
Our 2016 SPS salary survey results showcased significant diversity regarding factors that can influence salary compensation within this discipline. These data provided insights into the complex global job market trends. They also revealed the level of scientific specialization embedded within the organization, presently uniquely positioned to support the dynamic career paths of current and future safety pharmacologists.
安全药理学是一个不断发展的学科，科学家广泛分布于国际地理区域。本次电子薪资调查是首次在整个安全药理学会（SPS）会员中开展。向该学会的所有会员发送了一份电子调查问卷。分类调查问题评估了会员的就业类型、年收入、专业认证以及其他相关职业属性。
本次调查面向由在制药行业、合同研究组织（CRO）、监管机构、学术界或技术提供商行业全球工作的安全药理学家、毒理学家和药理学家组成的SPS会员。调查于2015年12月至2016年3月开放接受回复。
调查回复率为28%（129/453）。北美地区（68%）的受访者数量最多，其次是欧洲（28%）。大多数受访者（77%）拥有12年或更长时间的行业经验。52%的受访者年收入在4万美元至12万美元之间。正如预期的那样，薪资通常与行业经验年限或教育背景呈正相关，但薪资与直接监管的员工数量之间没有相关性。男性受访者的中位数薪资高于女性受访者，但中位数年龄也是如此，这表明不存在性别“薪资差距”。
我们2016年SPS薪资调查结果展示了该学科内影响薪资补偿的因素存在显著差异。这些数据为复杂的全球就业市场趋势提供了见解。它们还揭示了该组织内部的科学专业化水平，目前处于独特地位，能够支持当前和未来安全药理学家的动态职业发展路径。
